Description
Product Classification: Research-Use-Only (RUO)
Total Content: 10 mg lyophilized powder per vial
Compound: Melanotan II (MT-2) research peptide
Form: Sterile lyophilized peptide compound
Purity: ≥99%
Storage: Store at −20 °C, protected from light
Packaging: Glass vial in protective sleeve
Description
MT-2 (Melanotan II) 10 mg is a melanocortin research peptide designed for laboratory investigation of melanocortin receptor signaling pathways, receptor-mediated communication systems, neuroregulatory signaling activity, and biological-response mechanisms. Melanotan II is frequently studied in preclinical research involving melanocortin pathway interactions, receptor signaling activity, cellular communication systems, and peptide-signaling pathways. This pathway profile makes it useful for preclinical research into melanocortin biology, neuroregulatory communication, receptor activity, and peptide pathway modeling.
This compound is intended strictly for in vitro and preclinical laboratory research.
Applications
Intended for preclinical laboratory research only, including:
- Melanocortin receptor signaling studies
- Neuroregulatory pathway research
- Cellular communication investigations
- Receptor-signaling pathway analysis
- Peptide-signaling studies
- Biological-response experiments
- Comparative melanocortin pathway research
WARNING: Not for human or animal use. For research purposes only.
SCIENTIFIC REPORT
Abstract
Melanotan II is a synthetic melanocortin research peptide investigated for its role in receptor-mediated signaling, neuroregulatory communication, peptide-signaling activity, and biological-response mechanisms. This pathway profile allows researchers to model melanocortin signaling systems in controlled experimental environments. MT-2 10 mg is designed for laboratory use in studies examining receptor activity, cellular communication, biological-response pathways, neuroregulatory signaling systems, and downstream cellular responses associated with melanocortin pathway activation.
Mechanistic Pathway
MT-2 is designed around melanocortin receptor pathway modeling.
- Melanocortin Receptor Pathway
- Supports research into melanocortin signaling mechanisms
- Used in receptor-signaling and biological-response pathway models
- Studied for effects on downstream signaling activity
Effect: Models melanocortin receptor activity in controlled research systems.
Neuroregulatory Communication Pathway
- Supports investigation of neuroregulatory signaling mechanisms
- Used in cellular-response and receptor-signaling pathway models
- Helps study pathway interactions within biological systems
Effect: Enables research into neuroregulatory pathway contribution to melanocortin signaling.
Biological Response Pathway
- Supports research into biological-response mechanisms
- Used in receptor-signaling and neurobiological pathway models
- Helps evaluate pathway activity within biological systems
Effect: Provides a model for biological-response pathway research.
Pharmacokinetics / Research Profile
- Compound
- Pathway
- Research Notes
- Melanotan II (MT-2)
- Melanocortin Receptor Pathways
- Synthetic melanocortin peptide model for receptor-signaling research
Dosing Models in Research
Used only in controlled in vitro and preclinical research models to study receptor signaling and biological pathway response. No human or animal-use instructions are provided.
Preclinical Research Highlights
- Studied as a melanocortin receptor signaling model involving neuroregulatory pathways
- Used in cellular communication and biological-response pathway research
- Supports comparative studies involving receptor-signaling and melanocortin pathway systems
- Relevant to neuroregulatory signaling, receptor activity, and pathway cross-talk studies
- Useful for evaluating downstream effects of melanocortin pathway activation
Conclusion
MT-2 (Melanotan II) 10 mg offers a research-use-only model for studying melanocortin receptor pathway activation. By engaging receptor-signaling, neuroregulatory communication, and biological-response pathway models, it supports advanced preclinical investigation into peptide-signaling systems, melanocortin biology, cellular communication, and receptor pathway research.
